scorecardresearchGranules India Share Price Live NSE, BSE, Today - Granules India Stock
Mintgenie
Asian Paints3,207.0012.65 (0.40%)
Axis Bank1,130.354.15 (0.37%)
Bajaj Finance7,381.50-23.30 (-0.31%)
Bajaj Finserve1,704.559.95 (0.59%)
Bharti Airtel1,034.802.40 (0.23%)
HCL Technologies1,313.00-23.70 (-1.77%)
HDFC Bank1,624.8515.80 (0.98%)
Hindustan Unilever2,578.25-23.65 (-0.91%)
ICICI Bank1,008.9018.30 (1.85%)
ITC454.951.00 (0.22%)
Indusind Bank1,490.20-23.95 (-1.58%)
Infosys1,445.35-19.10 (-1.30%)
Kotak Mahindra Bank1,822.405.10 (0.28%)
Larsen & Toubro3,298.35-15.30 (-0.46%)
Mahindra & Mahindra1,690.7534.05 (2.06%)
Maruti Suzuki India10,665.0061.05 (0.58%)
NTPC275.550.75 (0.27%)
Nestle India24,485.8586.60 (0.35%)
Power Grid Corporation Of India216.203.30 (1.55%)
Reliance Industries2,430.659.65 (0.40%)
State Bank Of India607.0012.35 (2.08%)
Sun Pharmaceutical Industries1,233.051.60 (0.13%)
Tata Consultancy Services3,510.000.35 (0.01%)
Tata Motors707.151.70 (0.24%)
Tata Steel131.050.10 (0.08%)
Tech Mahindra1,211.75-11.80 (-0.96%)
Titan Company3,538.0050.30 (1.44%)
Ultratech Cement9,277.95-39.60 (-0.43%)
Wipro403.55-3.75 (-0.92%)

Granules India

BSE: 532482 | NSE: GRANULES | ISIN: INE101D01020 | SECTOR: Biotechnology & Drugs

₹389.80 -1.70 (-0.43%)

05 Dec 2023, 06:46 (IST)

  • Open

    391.35

  • High

    395.25

  • Low

    384.00

  • Prev Close

    391.50

  • P/E

    -

  • Median P/E

    -

  • P/B

    -

  • Median P/B

    -

  • Market Cap

    94.48B

  • Volume

    66.06K

  • Vol. (20 day Avg.)

    0

  • PEG

    -

  • Div.Yield

    -

  • Bid

    389.80

  • Ask

    390.20
View all metrics

Promoter Pledge Holding - 1.69%

Promoter NameNo of SharesPercentage
KRISHNA PRASAD CHIGURUPATI41,00,0001.69%

Company Description

  • Biotechnology & Drugs

  • BSE

    532482

  • NSE

    GRANULES

  • ISIN

    INE101D01020

Granules India Limited is an India-based pharmaceutical manufacturing company. The Company operates through its pharmaceuticals products segment. Its geographical segments include within India and outside India. The Company has its presence across the pharmaceutical manufacturing value chain, including active pharmaceutical ingredients (APIs), pharmaceutical formulation intermediaries (PFIs) and finished dosages (FDs). It has over eight manufacturing facilities, approximately seven of which are located in India and one in the United States. The Company sells its products in the global markets, including the United States of America, Canada, Latin America, Europe, Asia Pacific and India. The Company’s wholly owned subsidiaries include Granules USA Inc, Granules Pharmaceuticals Inc, Granules Europe Limited and Granules Lifesciences Private Limited.

Company Officers

  • Krishna Chigurupati

    Executive Chairman of the Board, Managing Director

  • Kandiraju Rao

    Chief Executive Officer, Joint Managing Director, Executive Director

  • Mukesh Surana

    Chief Financial Officer

  • Anil Arora

    Corporate Executive

  • Uma Rao G.

    Chief Human Resource Officer

  • Sanjay Kumar

    Senior Vice President - Corporate Strategy & Planning

  • G. N. Prashanth

    Senior Vice President & Head Corporate Quality

  • Manikandan Ramalingam

    Senior Vice President & Head Formulation R&D

  • Chaitanya Tummala

    Compliance Officer, Company Secretary

  • Harsha Chigurupati

    Non-Independent Executive Director